Rosemary oil vs minoxidil 2% for the treatment of androgenetic alopecia: a randomized comparative trial.

Abstract

Rosmarinus officinalis L. is a medicinal plant with diverse activities including enhancement microcapillary perfusion. The present study aimed to investigate the clinical efficacy of rosemary oil in the treatment of androgenetic alopecia (AGA) and compare its effects with minoxidil 2%. Patients with AGA were randomly assigned to rosemary oil (n = 50) or minoxidil 2% (n = 50) for a period of 6 months. After a baseline visit, patients returned to the clinic for efficacy and safety evaluations every 3 months. A standardized professional microphotographic assessment of each volunteer was taken at the initial interview and after 3 and 6 months of the trial. No significant change was observed in the mean hair count at the 3-month endpoint, neither in the rosemary nor in the minoxidil group (P > .05). In contrast, both groups experienced a significant increase in hair count at the 6-month endpoint compared with the baseline and 3-month endpoint (P < .05). No significant difference was found between the study groups regarding hair count either at month 3 or month 6 (> .05). The frequencies of dry hair, greasy hair, and dandruff were not found to be significantly different from baseline at either month 3 or month 6 trial in the groups (P > .05). The frequency of scalp itching at the 3- and 6-month trial points was significantly higher compared with baseline in both groups (P < .05). Scalp itching, however, was more frequent in the minoxidil group at both assessed endpoints (P < .05). The findings of the present trial provided evidence with respect to the efficacy of rosemary oil in the treatment of AGA.

• Authors: Yunes Panahi, Mohsen Taghizadeh, Eisa Tahmasbpour Marzony, Amirhossein Sahebkar
• Journal: Skinmed (Skinmed) 2015 Jan-Feb Vol. 13 Issue 1 Pg. 15-21 ISSN: 1540-9740 [Print] United States
• PMID: 25842469 (Publication Type: Comparative Study, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)

Chemical References

• Oils, Volatile
• Minoxidil
• rosemary oil

Topics

• Adult
• Alopecia (drug therapy)
• Hair (drug effects, growth & development)
• Humans
• Male
• Minoxidil (administration & dosage, adverse effects, therapeutic use)
• Oils, Volatile (administration & dosage, adverse effects, therapeutic use)
• Pruritus (epidemiology)
• Single-Blind Method
• Time Factors
• Treatment Outcome
• Young Adult